Tenaya Therapeutics Inc. (NASDAQ: TNYA) will present new clinical data from its RIDGE-1 Phase 1b/2 trial of TN-401 gene therapy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE